Increased DNA damage of adipose tissue-derived mesenchymal stem cells under inflammatory conditions

Zoltán G Páhi1,2, Diána Szűcs3,4,5, Vanda Miklós1,6

  • 1Hungarian Centre of Excellence for Molecular Medicine (HCEMM), Genome Integrity and DNA Repair Core Group, University of Szeged, Szeged, Hungary.

Heliyon
|September 19, 2024
PubMed

Insights

Mesenchymal stem cells (MSCs) show increased DNA repair activation after treatment with specific factors. This heightened repair may hinder effective stem cell transplantation and contribute to tumor formation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genomics

Background:

  • DNA repair is crucial for cellular homeostasis and genomic stability.
  • Stem cells (SCs) rely on DNA repair for their function and therapeutic applications.
  • Mesenchymal stem cells (MSCs) are vital for regenerative medicine and require effective DNA repair.

Purpose of the Study:

  • To investigate the impact of specific immune factors on DNA repair mechanisms in MSCs.
  • To analyze the transcriptional response of MSCs to various activating agents.
  • To understand how MSC induction affects DNA damage response pathways.

Main Methods:

  • Treatment of MSCs with lipopolysaccharide, tumor necrosis factor, interferon-gamma, polyinosinic acid, and interleukin 1 beta.
  • Monitoring cellular response using next-generation sequencing (NGS).
  • RNA sequencing to analyze gene expression changes, particularly in DNA damage response genes.

Main Results:

  • RNA sequencing revealed significant gene expression alterations in treated MSCs.
  • Elevated activation of DNA repair pathways was observed following MSC induction.
  • MSCs demonstrated a reduced capacity for senescence or apoptosis despite accumulating genetic lesions.

Conclusions:

  • Enhanced DNA repair activation in induced MSCs may compromise stem cell transplantation efficacy.
  • The dysregulation of DNA repair in MSCs could promote genetic instability and tumor initiation.
  • Further research is needed to optimize MSC activation protocols for therapeutic use.